Journal of Medical Microbiology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

MARGINAL NOTES, October 2023. It's about the phenotype
J Med Microbiol. 2023 Nov;72(10). doi: 10.1099/jmm.0.001773.NO ABSTRACTPMID:37916544 | DOI:10.1099/jmm.0.001773 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - November 2, 2023 Category: Microbiology Authors: Timothy J J Inglis Source Type: research

 In vitro activity of tubercidin against Mycobacterium tuberculosis and nontuberculosis Mycobacteria
In this study, the in vitro activity of tubercidin was evaluated against Mycobacterium tuberculosis (Mtb) and nontuberculosis Mycobacteria (NTM). For determining the MICs of tubercidin, 23 fully drug-sensitive (DS) Mtb strains, 33 multi-drug resistance tuberculosis (MDR-TB) strains, 29 pre-extensively drug-resistant tuberculosis (pre-XDR-TB) strains, 21 extensively drug-resistant tuberculosis (XDR-TB) strains, 17 rapidly growing mycobacteria (RGM) and nine slowly growing mycobacteria (SGM) references strains were tested by microplate-based Alamar Blue assay (MABA) method. The results indicate that tubercidin has high in vi...
Source: Journal of Medical Microbiology - November 1, 2023 Category: Microbiology Authors: Qing Sun Xinlei Liao Jun Yan Guanglu Jiang Fengmin Huo Guirong Wang Hao Li Source Type: research

Performance of targeted next-generation sequencing in the detection of respiratory pathogens and antimicrobial resistance genes for children
Conclusion. These results demonstrated the superiority of RPIP in pathogen detection, particularly for multiple and difficult-to-culture pathogens, as well as in predicting resistance to erythromycin and tetracycline, which has significance for the accurate diagnosis of pathogenic infection and in the guidance of clinical treatment.PMID:37910007 | DOI:10.1099/jmm.0.001771 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - November 1, 2023 Category: Microbiology Authors: Ruihong Lin Zhihao Xing Xiaorong Liu Qiang Chai Zefeng Xin Meng Huang Chunqing Zhu Ce Luan Hongdan Gao Yao Du Xuwen Deng Hetong Zhang Dongli Ma Source Type: research

Evaluation of anti-biofilm effect of antimicrobial sonodynamic therapy-based periodontal ligament stem cell-derived exosome-loaded kojic acid on Enterococcus faecalis biofilm
Conclusion. The KA@PDL-Exo-mediated aSDT was able to significantly reduce the E. faecalis load in pre-formed biofilms, decrease the expression of gelE and srpE mRNA, and increase the generation of endogenous ROS. These findings imply that KA@PDL-Exo-mediated aSDT could be a promising anti-biofilm strategy that requires additional in vitro and in vivo investigations.PMID:37910015 | DOI:10.1099/jmm.0.001772 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - November 1, 2023 Category: Microbiology Authors: Maryam Pourhajibagher Maryam Azimi Mohammadabadi Hassan-Ali Ghafari Mahshid Hodjat Abbas Bahador Source Type: research

Genomic analyses of Bacteroides fragilis : subdivisions I and II represent distinct species
Conclusion. The findings indicate that B. fragilis A, previously referred to as division II B. fragilis, is an individual species and distinct from B. fragilis sensu stricto. The B. fragilis pangenome analysis supported previous genomic, phylogenetic and resistome screening analyses collectively reinforcing that divisions I and II are two separate species. In addition, it was confirmed that differences in the accessory genes of B. fragilis divisions I and II are primarily associated with carbohydrate metabolism and suggest that differences other than antimicrobial resistance could also be used to distinguish between these ...
Source: Journal of Medical Microbiology - November 1, 2023 Category: Microbiology Authors: Jamie English Fiona Newberry Lesley Hoyles Sheila Patrick Linda Stewart Source Type: research

Explore intersection genes of oxymatrine and COVID-19 with lung cancer as potential therapeutic targets based on network pharmacology
Conclusion. To treat COVID-19 or lung cancer paired with COVID-19, oxymatrine may improve the therapeutic efficacy of current clinical antiviral medicines and immunotherapy.PMID:37855710 | DOI:10.1099/jmm.0.001766 (Source: Journal of Medical Microbiology)
Source: Journal of Medical Microbiology - October 19, 2023 Category: Microbiology Authors: Wei Wu Chuan Cheng Dongdong Yuan Li Peng Le Li Source Type: research